Header Logo

Udho Thadani

TitleProf Emeritus
InstitutionUniversity of Oklahoma Health Sciences Center
DepartmentMedicine Cardiology
AddressAAT 5400
800 Stanton L Young Blvd
Oklahoma City OK 73104
Phone405/271-4742
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Thadani U. Polypills: Common garden variety or precision formulated for improving cardiovascular outcomes: An ongoing challenge. Trends Cardiovasc Med. 2022 Feb 26. PMID: 35231614.
      Citations:    Fields:    
    2. Elkholey K, Papadimitriou L, Butler J, Thadani U, Stavrakis S. Effect of Obesity on Response to Spironolactone in Patients With Heart Failure With Preserved Ejection Fraction. Am J Cardiol. 2021 05 01; 146:36-47. PMID: 33529620.
      Citations: 3     Fields:    Translation:Humans
    3. Khattab M, Parwani P, Abbas M, Ali H, Lozano PM, Thadani U, Dasari TW. Utilization of guideline-directed medical therapy in patients with de novo heart failure with reduced ejection fraction: A Veterans Affairs study. J Family Med Prim Care. 2020 Jun; 9(6):3065-3069. PMID: 32984174.
      Citations:    
    4. Dasari TW, Patel B, Wayangankar SA, Alexander D, Zhao YD, Schlegel J, Leung C, Lozano P, Latif F, Thadani U. Prognostic Value of 6-Minute Walk Distance in Patients Undergoing Percutaneous Coronary Intervention: a Veterans Affairs Prospective Study. Tex Heart Inst J. 2020 02; 47(1):10-14. PMID: 32148446.
      Citations:    Fields:    Translation:Humans
    5. Thadani U. Trimetazidine for stable and unstable ischemic heart diseases and for heart failure: Is its routine use justified from available data? Int J Cardiol. 2020 02 01; 300:45-46. PMID: 31402158.
      Citations: 1     Fields:    Translation:Humans
    6. Rousan TA, Thadani U. Stable Angina Medical Therapy Management Guidelines: A Critical Review of Guidelines from the European Society of Cardiology and National Institute for Health and Care Excellence. Eur Cardiol. 2019 Apr; 14(1):18-22. PMID: 31131033.
      Citations:    
    7. Shah B, Thadani U. Trans fatty acids linked to myocardial infarction and stroke: What is the evidence? Trends Cardiovasc Med. 2019 07; 29(5):306-310. PMID: 31130187.
      Citations: 1     Fields:    Translation:HumansAnimalsPHPublic Health
    8. Thadani U. Editorial commentary: Treatment of refractory angina: An ongoing challenge. Trends Cardiovasc Med. 2018 04; 28(3):229-230. PMID: 29273184.
      Citations:    Fields:    Translation:Humans
    9. Rousan TA, Thadani U. Stent choice in cardiogenic shock complicating acute myocardial infarction likely does not affect mortality or reinfarction. Evid Based Med. 2017 12; 22(6):224. PMID: 29102922.
      Citations: 1     Fields:    
    10. Mathew ST, Po SS, Thadani U. Inappropriate sinus tachycardia-symptom and heart rate reduction with ivabradine: A pooled analysis of prospective studies. Heart Rhythm. 2018 02; 15(2):240-247. PMID: 29017929.
      Citations: 7     Fields:    Translation:Humans
    11. Thadani U. Routine invasive strategies compared with conservative strategies do not lower the all-cause mortality in patients with non-ST elevation myocardial infarction and unstable angina. Evid Based Med. 2017 10; 22(5):190. PMID: 28775170.
      Citations:    Fields:    Translation:Humans
    12. Rousan TA, Mathew ST, Thadani U. Drug Therapy for Stable Angina Pectoris. Drugs. 2017 Mar; 77(3):265-284. PMID: 28120185.
      Citations: 7     Fields:    Translation:Humans
    13. Rousan TA, Mathew ST, Thadani U. The risk of cardiovascular side effects with anti-anginal drugs. Expert Opin Drug Saf. 2016 Dec; 15(12):1609-1623. PMID: 27659354.
      Citations: 6     Fields:    Translation:HumansAnimals
    14. Thadani U. Management of Stable Angina - Current Guidelines: A Critical Appraisal. Cardiovasc Drugs Ther. 2016 Aug; 30(4):419-426. PMID: 27638354.
      Citations: 10     Fields:    Translation:Humans
    15. Mathew ST, Pakala AV, Thadani U. Invasive strategy in acute coronary syndrome. Lancet. 2016 Jun 18; 387(10037):2503-4. PMID: 27353678.
      Citations:    Fields:    Translation:Humans
    16. Patel N, Ju C, Macon C, Thadani U, Schulte PJ, Hernandez AF, Bhatt DL, Butler J, Yancy CW, Fonarow GC. Temporal Trends of Digoxin Use in Patients Hospitalized With Heart Failure: Analysis From the American Heart Association Get With The Guidelines-Heart Failure Registry. JACC Heart Fail. 2016 05; 4(5):348-56. PMID: 26874392.
      Citations: 12     Fields:    Translation:Humans
    17. Patel N, Patel NJ, Thakkar B, Singh V, Arora S, Patel N, Savani C, Deshmukh A, Thadani U, Badheka AO, Alfonso C, Fonarow GC, Cohen MG. Management Strategies and Outcomes of ST-Segment Elevation Myocardial Infarction Patients Transferred After Receiving Fibrinolytic Therapy in the United States. Clin Cardiol. 2016 Jan; 39(1):9-18. PMID: 26785349.
      Citations: 3     Fields:    Translation:Humans
    18. Thadani U, Latif F. Percutaneous coronary interventions in the elderly improve quality of life: evidence far from certain. Cardiology. 2014; 129(1):44-5. PMID: 25096401.
      Citations:    Fields:    Translation:Humans
    19. Thadani U. Challenges with nitrate therapy and nitrate tolerance: prevalence, prevention, and clinical relevance. Am J Cardiovasc Drugs. 2014 Aug; 14(4):287-301. PMID: 24664980.
      Citations: 6     Fields:    Translation:Humans
    20. Thadani U, Latif F. Pigment epithelial-derived factor and acute coronary syndrome: a novel protective biomarker but not for routine clinical use at present. Cardiology. 2014; 127(1):28-30. PMID: 24192803.
      Citations: 1     Fields:    Translation:Humans
    21. Golwala HB, Thadani U, Liang L, Stavrakis S, Butler J, Yancy CW, Bhatt DL, Hernandez AF, Fonarow GC. Use of hydralazine-isosorbide dinitrate combination in African American and other race/ethnic group patients with heart failure and reduced left ventricular ejection fraction. J Am Heart Assoc. 2013 Aug 21; 2(4):e000214. PMID: 23966379.
      Citations: 11     Fields:    Translation:Humans
    22. McCullough PA, Barnard D, Clare R, Ellis SJ, Fleg JL, Fonarow GC, Franklin BA, Kilpatrick RD, Kitzman DW, O'Connor CM, Piña IL, Thadani U, Thohan V, Whellan DJ. Anemia and associated clinical outcomes in patients with heart failure due to reduced left ventricular systolic function. Clin Cardiol. 2013 Oct; 36(10):611-20. PMID: 23929781.
      Citations: 6     Fields:    Translation:Humans
    23. Thadani U, Latif F. Retroperitoneal hemorrhage after cardiac catheterization and percutaneous coronary interventions. Cardiology. 2013; 126(1):24-6. PMID: 23860184.
      Citations:    Fields:    Translation:Humans
    24. Dasari TW, Golwala H, Koehler M, Wayangankar S, Pakala A, Schechter E, Lozano P, Abu-Fadel MS, Latif F, Thadani U. Is risk factor control and guideline-based medical therapy optimal in patients with nonobstructive coronary artery disease? A Veterans Affairs study. Am J Med Sci. 2013 May; 345(5):339-42. PMID: 23044654.
      Citations:    Fields:    Translation:Humans
    25. Stavrakis S, Pakala A, Thomas J, Chaudhry MA, Thadani U. Obesity, brain natriuretic peptide levels and mortality in patients hospitalized with heart failure and preserved left ventricular systolic function. Am J Med Sci. 2013 Mar; 345(3):211-7. PMID: 23422653.
      Citations: 10     Fields:    Translation:HumansCTClinical Trials
    26. Thadani U. Should ranolazine be used for all patients with ischemic heart disease or only for symptomatic patients with stable angina or for those with refractory angina pectoris? A critical appraisal. Expert Opin Pharmacother. 2012 Dec; 13(17):2555-63. PMID: 23121448.
      Citations: 5     Fields:    Translation:Humans
    27. Thadani U. Osteoprotegerin and ST segment myocardial infarction: a novel risk marker but not for routine use at present. Cardiology. 2012; 123(2):91-3. PMID: 23018624.
      Citations:    Fields:    Translation:Humans
    28. Boden WE, Finn AV, Patel D, Peacock WF, Thadani U, Zimmerman FH. Nitrates as an integral part of optimal medical therapy and cardiac rehabilitation for stable angina: review of current concepts and therapeutics. Clin Cardiol. 2012 May; 35(5):263-71. PMID: 22528319.
      Citations: 10     Fields:    Translation:Humans
    29. Thadani U, Wittig T. A randomized, double-blind, placebo-controlled, crossover, dose-ranging multicenter study to determine the effect of sublingual nitroglycerin spray on exercise capacity in patients with chronic stable angina. Clin Med Insights Cardiol. 2012; 6:87-95. PMID: 22566749.
      Citations:    
    30. Piller LB, Baraniuk S, Simpson LM, Cushman WC, Massie BM, Einhorn PT, Oparil S, Ford CE, Graumlich JF, Dart RA, Parish DC, Retta TM, Cuyjet AB, Jafri SZ, Furberg CD, Saklayen MG, Thadani U, Probstfield JL, Davis BR. Long-term follow-up of participants with heart failure in the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). Circulation. 2011 Oct 25; 124(17):1811-8. PMID: 21969009.
      Citations: 16     Fields:    Translation:Humans
    31. Stavrakis S, Lazzara R, Thadani U. The benefit of cardiac resynchronization therapy and QRS duration: a meta-analysis. J Cardiovasc Electrophysiol. 2012 Feb; 23(2):163-8. PMID: 21815961.
      Citations: 22     Fields:    Translation:Humans
    32. Gardner AW, Montgomery PS, Ritti-Dias RM, Thadani U. Exercise performance, physical activity, and health-related quality of life in participants with stable angina. Angiology. 2011 Aug; 62(6):461-6. PMID: 21421630.
      Citations: 12     Fields:    Translation:Humans
    33. Stavrakis S, Stoner JA, Azar M, Wayangankar S, Thadani U. Low-dose aspirin for primary prevention of cardiovascular events in patients with diabetes: a meta-analysis. Am J Med Sci. 2011 Jan; 341(1):1-9. PMID: 21191260.
      Citations: 12     Fields:    Translation:HumansPHPublic Health
    34. Keteyian SJ, Isaac D, Thadani U, Roy BA, Bensimhon DR, McKelvie R, Russell SD, Hellkamp AS, Kraus WE. Safety of symptom-limited cardiopulmonary exercise testing in patients with chronic heart failure due to severe left ventricular systolic dysfunction. Am Heart J. 2009 Oct; 158(4 Suppl):S72-7. PMID: 19782792.
      Citations: 16     Fields:    Translation:Humans
    35. Patel JH, Stoner JA, Owora A, Mathew ST, Thadani U. Evidence for using clopidogrel alone or in addition to aspirin in post coronary artery bypass surgery patients. Am J Cardiol. 2009 Jun 15; 103(12):1687-93. PMID: 19539077.
      Citations: 7     Fields:    Translation:Humans
    36. Thadani U. Treatment with statins in high-risk patients: relevance of time to titration of dose and adverse outcomes. Am J Cardiovasc Drugs. 2009; 9(3):211-2; author reply 212. PMID: 19463025.
      Citations:    Fields:    Translation:Humans
    37. Thadani U, Jacob RG. Isosorbide dinitrate/hydralazine: its role in the treatment of heart failure. Drugs Today (Barc). 2008 Dec; 44(12):925-37. PMID: 19198701.
      Citations: 2     Fields:    Translation:HumansAnimals
    38. Black HR, Davis B, Barzilay J, Nwachuku C, Baimbridge C, Marginean H, Wright JT, Basile J, Wong ND, Whelton P, Dart RA, Thadani U. Metabolic and clinical outcomes in nondiabetic individuals with the metabolic syndrome assigned to chlorthalidone, amlodipine, or lisinopril as initial treatment for hypertension: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Diabetes Care. 2008 Feb; 31(2):353-60. PMID: 18000186.
      Citations: 37     Fields:    Translation:Humans
    39. Thadani U, Ripley TL. Side effects of using nitrates to treat heart failure and the acute coronary syndromes, unstable angina and acute myocardial infarction. Expert Opin Drug Saf. 2007 Jul; 6(4):385-96. PMID: 17688382.
      Citations: 8     Fields:    Translation:HumansAnimals
    40. Thadani U, Rodgers T. Side effects of using nitrates to treat angina. Expert Opin Drug Saf. 2006 Sep; 5(5):667-74. PMID: 16907656.
      Citations: 22     Fields:    Translation:Humans
    41. Leenen FH, Nwachuku CE, Black HR, Cushman WC, Davis BR, Simpson LM, Alderman MH, Atlas SA, Basile JN, Cuyjet AB, Dart R, Felicetta JV, Grimm RH, Haywood LJ, Jafri SZ, Proschan MA, Thadani U, Whelton PK, Wright JT. Clinical events in high-risk hypertensive patients randomly assigned to calcium channel blocker versus angiotensin-converting enzyme inhibitor in the antihypertensive and lipid-lowering treatment to prevent heart attack trial. Hypertension. 2006 Sep; 48(3):374-84. PMID: 16864749.
      Citations: 48     Fields:    Translation:Humans
    42. Thadani U. Selection of optimal therapy for chronic stable angina. Curr Treat Options Cardiovasc Med. 2006 Feb; 8(1):23-35. PMID: 16401381.
      Citations:    
    43. Vicari RM, Chaitman B, Keefe D, Smith WB, Chrysant SG, Tonkon MJ, Bittar N, Weiss RJ, Morales-Ballejo H, Thadani U. Efficacy and safety of fasudil in patients with stable angina: a double-blind, placebo-controlled, phase 2 trial. J Am Coll Cardiol. 2005 Nov 15; 46(10):1803-11. PMID: 16286163.
      Citations: 72     Fields:    Translation:HumansCTClinical Trials
    44. Abrams J, Thadani U. Therapy of stable angina pectoris: the uncomplicated patient. Circulation. 2005 Oct 11; 112(15):e255-9. PMID: 16216965.
      Citations: 11     Fields:    Translation:Humans
    45. Whelton PK, Barzilay J, Cushman WC, Davis BR, Iiamathi E, Kostis JB, Leenen FH, Louis GT, Margolis KL, Mathis DE, Moloo J, Nwachuku C, Panebianco D, Parish DC, Pressel S, Simmons DL, Thadani U. Clinical outcomes in antihypertensive treatment of type 2 diabetes, impaired fasting glucose concentration, and normoglycemia: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Arch Intern Med. 2005 Jun 27; 165(12):1401-9. PMID: 15983290.
      Citations: 59     Fields:    Translation:HumansCTClinical Trials
    46. Thadani U. Can nicorandil treat angina pectoris effectively? Nat Clin Pract Cardiovasc Med. 2005 Apr; 2(4):186-7. PMID: 16265479.
      Citations: 4     Fields:    
    47. Thadani U. Modified-release formulation of trimetazidine for exceptional control of angina pectoris: fact or fiction. Am J Cardiovasc Drugs. 2005; 5(5):331-4. PMID: 16156689.
      Citations: 3     Fields:    Translation:Humans
    48. Thadani U. Prevention of nitrate tolerance with angiotensin II receptor type 1 blocker in patients with stable angina: yet another failed strategy to prevent tolerance. Cardiovasc Drugs Ther. 2004 Sep; 18(5):339-42. PMID: 15717134.
      Citations: 1     Fields:    Translation:Humans
    49. Thadani U. Current medical management of chronic stable angina. J Cardiovasc Pharmacol Ther. 2004 Sep; 9 Suppl 1:S11-29; quiz S98-9. PMID: 15378129.
      Citations: 13     Fields:    Translation:HumansAnimals
    50. Thadani U. Recurrent and refractory angina following revascularization procedures in patients with stable angina pectoris. Coron Artery Dis. 2004 May; 15 Suppl 1:S1-4. PMID: 15179121.
      Citations: 5     Fields:    Translation:Humans
    51. Pepine CJ, Rouleau JL, Annis K, Ducharme A, Ma P, Lenis J, Davies R, Thadani U, Chaitman B, Haber HE, Freedman SB, Pressler ML, Pitt B. Effects of angiotensin-converting enzyme inhibition on transient ischemia: the Quinapril Anti-Ischemia and Symptoms of Angina Reduction (QUASAR) trial. J Am Coll Cardiol. 2003 Dec 17; 42(12):2049-59. PMID: 14680725.
      Citations: 7     Fields:    Translation:HumansCTClinical Trials
    52. Fox KM, Thadani U, Ma PT, Nash SD, Keating Z, Czorniak MA, Gillies H, Keltai M. Sildenafil citrate does not reduce exercise tolerance in men with erectile dysfunction and chronic stable angina. Eur Heart J. 2003 Dec; 24(24):2206-12. PMID: 14659772.
      Citations: 16     Fields:    Translation:HumansCTClinical Trials
    53. Pepine CJ, Cooper-DeHoff RM, Weiss RJ, Koren M, Bittar N, Thadani U, Minkwitz MC, Michelson EL, Hutchinson HG. Comparison of effects of nisoldipine-extended release and amlodipine in patients with systemic hypertension and chronic stable angina pectoris. Am J Cardiol. 2003 Feb 01; 91(3):274-9. PMID: 12565082.
      Citations: 7     Fields:    Translation:HumansCTClinical Trials
    54. Thadani U, Smith W, Nash S, Bittar N, Glasser S, Narayan P, Stein RA, Larkin S, Mazzu A, Tota R, Pomerantz K, Sundaresan P. The effect of vardenafil, a potent and highly selective phosphodiesterase-5 inhibitor for the treatment of erectile dysfunction, on the cardiovascular response to exercise in patients with coronary artery disease. J Am Coll Cardiol. 2002 Dec 04; 40(11):2006-12. PMID: 12475462.
      Citations: 30     Fields:    Translation:HumansCTClinical Trials
    55. Thadani U. Selective L-type, T-type, and nonspecific calcium-channel blockers for stable angina pectoris. Am Heart J. 2002 Jul; 144(1):8-10. PMID: 12094182.
      Citations: 1     Fields:    Translation:Humans
    56. Philbin EF, Hunsberger S, Garg R, Lader E, Thadani U, McSherry F, Silver MA. Usefulness of clinical information to distinguish patients with normal from those with low ejection fractions in heart failure. Am J Cardiol. 2002 May 15; 89(10):1218-21. PMID: 12008182.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    57. Kostis JB, Dockens RC, Thadani U, Bethala V, Pepine C, Leimbach W, Vachharajani N, Raymond RH, Stouffer BC, Tay LK, Shyu WC, Liao WC. Comparison of pharmacokinetics of lanoteplase and alteplase during acute myocardial infarction. Clin Pharmacokinet. 2002; 41(6):445-52. PMID: 12074692.
      Citations: 3     Fields:    Translation:HumansCTClinical Trials
    58. Hamilton SF, Houle LM, Thadani U. Rapid-release and coat-core formulations of nisoldipine in treatment of hypertension, angina, and heart failure. Heart Dis. 1999 Nov-Dec; 1(5):279-88. PMID: 11720635.
      Citations:    Fields:    Translation:Humans
    59. Thadani U. Treatment of stable angina. Curr Opin Cardiol. 1999 Jul; 14(4):349-58. PMID: 10448616.
      Citations: 5     Fields:    Translation:HumansAnimals
    60. den Heijer P, Vermeer F, Ambrosioni E, Sadowski Z, López-Sendón JL, von Essen R, Beaufils P, Thadani U, Adgey J, Pierard L, Brinker J, Davies RF, Smalling RW, Wallentin L, Caspi A, Pangerl A, Trickett L, Hauck C, Henry D, Chew P. Evaluation of a weight-adjusted single-bolus plasminogen activator in patients with myocardial infarction: a double-blind, randomized angiographic trial of lanoteplase versus alteplase. Circulation. 1998 Nov 17; 98(20):2117-25. PMID: 9815865.
      Citations: 18     Fields:    Translation:HumansCTClinical Trials
    61. Ma L, Yu Z, Xiao S, Thadani U, Robinson CP, Patterson E. Supersensitivity to serotonin- and histamine-induced arterial contraction following ovariectomy. Eur J Pharmacol. 1998 Oct 23; 359(2-3):191-200. PMID: 9832391.
      Citations: 3     Fields:    Translation:Animals
    62. Asirvatham S, Sebastian C, Thadani U. Choosing the most appropriate treatment for stable angina. Safety considerations. Drug Saf. 1998 Jul; 19(1):23-44. PMID: 9673856.
      Citations: 11     Fields:    Translation:Humans
    63. Thadani U, Roden DM. FDA Panel report: January 1998. Circulation. 1998 Jun 16; 97(23):2295-6. PMID: 9639370.
      Citations: 1     Fields:    Translation:Humans
    64. Asirvatham S, Sebastian C, Thadani U. Severe symptomatic sinus bradycardia associated with mesalamine use. Am J Gastroenterol. 1998 Mar; 93(3):470-1. PMID: 9517663.
      Citations: 2     Fields:    Translation:Humans
    65. Patterson E, Ma L, Szabo B, Robinson CP, Thadani U. Ovariectomy and estrogen-induced alterations in myocardial contractility in female rabbits: role of the L-type calcium channel. J Pharmacol Exp Ther. 1998 Feb; 284(2):586-91. PMID: 9454801.
      Citations: 16     Fields:    Translation:Animals
    66. Deedwania PC, Pool PE, Thadani U, Eff J. Effect of morning versus evening dosing of diltiazem on myocardial ischemia detected by ambulatory electrocardiographic monitoring in chronic stable angina pectoris. Dilacor XR Ambulatory Ischemia Study Group. Am J Cardiol. 1997 Aug 15; 80(4):421-5. PMID: 9285652.
      Citations: 2     Fields:    Translation:HumansCTClinical Trials
    67. Kamalesh M, Chandrasekaran K, Sivaram CA, Thadani U. Lack of arrhythmogenicity with ST-segment elevation during high-dose of dobutamine atropine stress in patients with documented or suspected coronary artery disease. Am J Cardiol. 1997 Aug 01; 80(3):341-3. PMID: 9264431.
      Citations: 1     Fields:    Translation:Humans
    68. Ma L, Robinson CP, Thadani U, Patterson E. Effect of 17-beta estradiol in the rabbit: endothelium-dependent and -independent mechanisms of vascular relaxation. J Cardiovasc Pharmacol. 1997 Jul; 30(1):130-5. PMID: 9268232.
      Citations: 2     Fields:    Translation:Animals
    69. Thadani U. Management of patients with chronic stable angina at low risk for serious cardiac events. Am J Cardiol. 1997 Jun 26; 79(12B):24-30. PMID: 9223354.
      Citations: 4     Fields:    Translation:Humans
    70. Glasser SP, Michie DD, Thadani U, Baiker WM. Effects of zatebradine (ULFS 49 CL), a sinus node inhibitor, on heart rate and exercise duration in chronic stable angina pectoris. Zatebradine Investigators. Am J Cardiol. 1997 May 15; 79(10):1401-5. PMID: 9165168.
      Citations: 4     Fields:    Translation:HumansCTClinical Trials
    71. Thadani U. Oral nitrates: more than symptomatic therapy in coronary artery disease? Cardiovasc Drugs Ther. 1997 May; 11 Suppl 1:213-8. PMID: 9211013.
      Citations: 8     Fields:    Translation:Humans
    72. Alpert JS, Kobrin I, DeQuattro V, Friedman R, Shepherd A, Fenster PE, Thadani U. Additional antianginal and anti-ischemic efficacy of mibefradil in patients pretreated with a beta blocker for chronic stable angina pectoris. Am J Cardiol. 1997 Apr 15; 79(8):1025-30. PMID: 9114758.
      Citations: 3     Fields:    Translation:HumansCTClinical Trials
    73. Thadani U. Nitrate tolerance, rebound, and their clinical relevance in stable angina pectoris, unstable angina, and heart failure. Cardiovasc Drugs Ther. 1997 Jan; 10(6):735-42. PMID: 9110117.
      Citations: 17     Fields:    Translation:Humans
    74. Thadani U. Secondary preventive potential of nitrates in ischaemic heart disease. Eur Heart J. 1996 Dec; 17 Suppl F:30-6. PMID: 8960445.
      Citations:    Fields:    Translation:Humans
    75. Ma L, Hsu CH, Patterson E, Thadani U, Robinson CP. Ricin depresses cardiac function in the rabbit heart. Toxicol Appl Pharmacol. 1996 May; 138(1):72-6. PMID: 8658515.
      Citations: 3     Fields:    Translation:Animals
    76. Thadani U. Hypertension and cardiovascular disease risk in women. Med Sci Sports Exerc. 1996 Jan; 28(1):7-8. PMID: 8775345.
      Citations:    Fields:    Translation:Humans
    77. Thadani U, Chohan A. Chronic stable angina pectoris. Postgrad Med. 1995 Dec; 98(6):175-188. PMID: 29224440.
      Citations:    Fields:    
    78. Ma L, Hsu CH, Fugate R, Patterson E, Thadani U, Robinson CP. Ricin disturbs calcium homeostasis in the rabbit heart. J Biochem Toxicol. 1995 Dec; 10(6):323-8. PMID: 8934635.
      Citations:    Fields:    Translation:AnimalsCells
    79. Thadani U, Chohan A. Chronic stable angina pectoris. Strategies for effective drug therapy. Postgrad Med. 1995 Dec; 98(6):175-6, 179-83, 187-8. PMID: 7501578.
      Citations: 5     Fields:    Translation:Humans
    80. Ezekowitz MD, Hossack K, Mehta JL, Thadani U, Weidler DJ, Kostuk W, Awan N, Grossman W, Bommer W. Amlodipine in chronic stable angina: results of a multicenter double-blind crossover trial. Am Heart J. 1995 Mar; 129(3):527-35. PMID: 7872184.
      Citations: 9     Fields:    Translation:HumansCTClinical Trials
    81. Thadani U, Opie LH. Nitrates for unstable angina. Cardiovasc Drugs Ther. 1994 Oct; 8(5):719-26. PMID: 7873468.
      Citations: 1     Fields:    
    82. Pool PE, Thadani U, Miller AB, Fromell GJ, Eff J. Conversion from immediate-release to extended-release diltiazem in angina pectoris. Clin Cardiol. 1994 Sep; 17(9):484-8. PMID: 8001312.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    83. Thadani U, Ezekowitz M, Fenney L, Chiang YK. Double-blind efficacy and safety study of a novel anti-ischemic agent, ranolazine, versus placebo in patients with chronic stable angina pectoris. Ranolazine Study Group. Circulation. 1994 Aug; 90(2):726-34. PMID: 8044941.
      Citations: 13     Fields:    Translation:HumansCTClinical Trials
    84. Pepine CJ, Cohn PF, Deedwania PC, Gibson RS, Handberg E, Hill JA, Miller E, Marks RG, Thadani U. Effects of treatment on outcome in mildly symptomatic patients with ischemia during daily life. The Atenolol Silent Ischemia Study (ASIST) Circulation. 1994 Aug; 90(2):762-8. PMID: 8044945.
      Citations: 36     Fields:    Translation:HumansCTClinical Trials
    85. Thadani U, Lipicky RJ. Short and long-acting oral nitrates for stable angina pectoris. Cardiovasc Drugs Ther. 1994 Aug; 8(4):611-23. PMID: 7848896.
      Citations: 13     Fields:    Translation:HumansCTClinical Trials
    86. Thadani U, Lipicky RJ. Ointments and transdermal nitroglycerin patches for stable angina pectoris. Cardiovasc Drugs Ther. 1994 Aug; 8(4):625-33. PMID: 7848897.
      Citations: 6     Fields:    Translation:HumansCTClinical Trials
    87. Thadani U, Glasser S, Bittar N, Beach CL. Dose-response evaluation of once-daily therapy with a new formulation of diltiazem for stable angina pectoris. Diltiazem CD Study Group. Am J Cardiol. 1994 Jul 01; 74(1):9-17. PMID: 8017316.
      Citations: 7     Fields:    Translation:HumansCTClinical Trials
    88. Thadani U, Chrysant S, Gorwit J, Giles T, Archer S, Iteld B, Singh S, Copen D, Wakeford C, Hobbs S. Duration of effects of isradipine during twice daily therapy in angina pectoris. Cardiovasc Drugs Ther. 1994 Apr; 8(2):199-210. PMID: 7918132.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    89. Thadani U, Maranda CR, Amsterdam E, Spaccavento L, Friedman RG, Chernoff R, Zellner S, Gorwit J, Hinderaker PH. Lack of pharmacologic tolerance and rebound angina pectoris during twice-daily therapy with isosorbide-5-mononitrate. Ann Intern Med. 1994 Mar 01; 120(5):353-9. PMID: 8093132.
      Citations: 11     Fields:    Translation:HumansCTClinical Trials
    90. Frishman WH, Amsterdam E, Glasser SP, Thadani U. Mononitrates: defining the ideal long-acting nitrate. Clin Ther. 1994 Mar-Apr; 16(2):130-9; discussion 129. PMID: 7914830.
      Citations:    Fields:    Translation:Humans
    91. Thadani U. Nitrate therapy and the development of tolerance. Arch Fam Med. 1993 Aug; 2(8):880-5. PMID: 8141915.
      Citations: 1     Fields:    Translation:Humans
    92. Kalbfleisch JM, Kurnik PB, Thadani U, DeWood MA, Kent R, Magorien RD, Jain AC, Spaccavento LJ, Morris DL, Taylor GJ, et al. Myocardial infarct artery patency and reocclusion rates after treatment with duteplase at the dose used in the International Study of Infarct Survival-3. Burroughs Wellcome Study Group. Am J Cardiol. 1993 Feb 15; 71(5):386-92. PMID: 8430624.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    93. Thadani U, de Vane PJ. Efficacy of isosorbide mononitrate in angina pectoris. Am J Cardiol. 1992 Nov 27; 70(17):67G-71G. PMID: 1449103.
      Citations: 2     Fields:    Translation:Humans
    94. Thadani U. Role of nitrates in angina pectoris. Am J Cardiol. 1992 Sep 24; 70(8):43B-53B. PMID: 1529926.
      Citations: 9     Fields:    Translation:Humans
    95. Thadani U, Bittar N. Effects of 8:00 a.m. and 2:00 p.m. doses of isosorbide-5-mononitrate during twice-daily therapy in stable angina pectoris. Am J Cardiol. 1992 Aug 01; 70(3):286-92. PMID: 1632390.
      Citations: 6     Fields:    Translation:HumansCTClinical Trials
    96. Kalbfleisch J, Thadani U, LittleJohn JK, Brown G, Magorien R, Kutcher M, Taylor G, Maddox WT, Campbell WB, Perry J, et al. Evaluation of a prolonged infusion of recombinant tissue-type plasminogen activator (Duteplase) in preventing reocclusion following successful thrombolysis in acute myocardial infarction. Am J Cardiol. 1992 May 01; 69(14):1120-7. PMID: 1575179.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    97. Thadani U. Nitrate tolerance. How to prevent it or minimize its effect. Postgrad Med. 1992 Apr; 91(5):307-12, 315-8. PMID: 1561169.
      Citations: 2     Fields:    Translation:Humans
    98. Pamulapati M, Teague S, Stelzer P, Thadani U. Successful surgical repair of a ruptured aneurysm of the sinus of Valsalva in early pregnancy. Ann Intern Med. 1991 Dec 01; 115(11):880-2. PMID: 1952476.
      Citations: 7     Fields:    Translation:Humans
    99. Thadani U, Zellner SR, Glasser S, Bittar N, Montoro R, Miller AB, Chaitman B, Schulman P, Stahl A, DiBianco R, et al. Double-blind, dose-response, placebo-controlled multicenter study of nisoldipine. A new second-generation calcium channel blocker in angina pectoris. Circulation. 1991 Dec; 84(6):2398-408. PMID: 1959195.
      Citations: 8     Fields:    Translation:HumansCTClinical Trials
    100. Thadani U, Whitsett TL. Beta-adrenergic blockers and intermittent claudication. Time for reappraisal. Arch Intern Med. 1991 Sep; 151(9):1705-7. PMID: 1679623.
      Citations: 4     Fields:    Translation:Humans
    101. Thadani U. Medical therapy of stable angina pectoris. Cardiol Clin. 1991 Feb; 9(1):73-87. PMID: 1674227.
      Citations: 8     Fields:    Translation:Humans
    102. Swartz SL, Gonasun LM, McAllister RG, Thadani U. A multicenter comparison of isradipine and prazosin for treatment of essential hypertension. Cardiovasc Drugs Ther. 1990 Apr; 4(2):413-7. PMID: 2149512.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    103. Thadani U. Amlodipine: a once-daily calcium antagonist in the treatment of angina pectoris--a parallel dose-response, placebo-controlled study. The Amlodipine Study Group. Am Heart J. 1989 Nov; 118(5 Pt 2):1135. PMID: 2530876.
      Citations: 4     Fields:    Translation:HumansCTClinical Trials
    104. Thadani U, Whitsett T, Hamilton SF. Nitrate therapy for myocardial ischemic syndrome: current perspectives including tolerance. Curr Probl Cardiol. 1988 Nov; 13(11):723-84. PMID: 3069336.
      Citations: 8     Fields:    Translation:Humans
    105. Thadani U, Whitsett T. Relationship of pharmacokinetic and pharmacodynamic properties of the organic nitrates. Clin Pharmacokinet. 1988 Jul; 15(1):32-43. PMID: 3135973.
      Citations: 7     Fields:    Translation:HumansAnimals
    106. Sung BH, Wilson MF, Robinson C, Thadani U, Lovallo WR. Mechanisms of myocardial ischemia induced by epinephrine: comparison with exercise-induced ischemia. Psychosom Med. 1988 Jul-Aug; 50(4):381-93. PMID: 3413271.
      Citations: 2     Fields:    Translation:Humans
    107. Sharma MK, Voyles W, Prasad R, Teague SM, Thadani U. Long-term bepridil monotherapy for angina pectoris. Am J Cardiol. 1988 Jun 01; 61(15):1210-3. PMID: 3287882.
      Citations: 2     Fields:    Translation:HumansCTClinical Trials
    108. Sung BH, Robinson C, Thadani U, Lee R, Wilson MF. Effects of 1-epinephrine on hemodynamics and cardiac function in coronary disease: dose-response studies. Clin Pharmacol Ther. 1988 Mar; 43(3):308-16. PMID: 3345621.
      Citations: 1     Fields:    Translation:Humans
    109. Goli VD, Teague SM, Prasad R, Harvey J, Voyles WF, Olson EG, Schechter E, Thadani U. Noninvasive evaluation of aortic stenosis severity utilizing Doppler ultrasound and electrical bioimpedance. J Am Coll Cardiol. 1988 Jan; 11(1):66-71. PMID: 3335708.
      Citations: 9     Fields:    Translation:Humans
    110. Thadani U. Amlodipine--a once-daily calcium antagonist in the treatment of angina pectoris: a parallel dose-response placebo-controlled study. J Cardiovasc Pharmacol. 1988; 12 Suppl 7:S114. PMID: 2467120.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    111. Thadani U, Prasad R, Hamilton SF, Voyles W, Doyle R, Karpow S, Reder R, Teague SM. Usefulness of twice-daily isosorbide-5-mononitrate in preventing development of tolerance in angina pectoris. Am J Cardiol. 1987 Sep 01; 60(7):477-82. PMID: 3630929.
      Citations: 7     Fields:    Translation:HumansCTClinical Trials
    112. Thadani U, Prasad R, Hamilton SF, Voyles WF, Doyle R, Karpow SA, Reder R, Teague SM. Isosorbide-5-mononitrate in angina pectoris: plasma concentrations and duration of effects after acute therapy. Clin Pharmacol Ther. 1987 Jul; 42(1):58-65. PMID: 3595067.
      Citations: 2     Fields:    Translation:HumansCTClinical Trials
    113. Thadani U, Whitsett TL. Nitrate therapy: continuous or pulse dosing. Ration Drug Ther. 1987 Jul; 21(7):1-6. PMID: 3124208.
      Citations: 1     Fields:    Translation:Humans
    114. Thadani U, Hamilton SF, Olson E, Anderson JL, Prasad R, Voyles W, Doyle R, Kirsten E, Teague SM. Duration of effects and tolerance of slow-release isosorbide-5-mononitrate for angina pectoris. Am J Cardiol. 1987 Apr 01; 59(8):756-62. PMID: 3825935.
      Citations: 14     Fields:    Translation:HumansCTClinical Trials
    115. Goli VD, Thadani U, Thomas SR, Voyles WF, Teague SM. Doppler echocardiographic profiles in obstructive right and left atrial myxomas. J Am Coll Cardiol. 1987 Mar; 9(3):701-3. PMID: 3819213.
      Citations:    Fields:    Translation:Humans
    116. Fenster PE, Reynolds D, Horwitz LD, Morrison D, Goldman S, Thadani U, Lazzara R, Serokman R, Marcus FI. Atenolol for ventricular ectopy: a dose-response study. Clin Pharmacol Ther. 1987 Jan; 41(1):118-23. PMID: 3802701.
      Citations: 2     Fields:    Translation:HumansCTClinical Trials
    117. Thadani U. The effectiveness of transcutaneous nitrate preparations for angina pectoris. Int J Cardiol. 1987 Jan; 14(1):9-14. PMID: 3100461.
      Citations: 2     Fields:    Translation:HumansCTClinical Trials
    118. Harvey JR, Teague SM, Anderson JL, Voyles WF, Thadani U. Clinically silent atrial septal defects with evidence for cerebral embolization. Ann Intern Med. 1986 Nov; 105(5):695-7. PMID: 3767150.
      Citations: 17     Fields:    Translation:Humans
    119. Puls A, Thadani U. Rupture of abdominal aortic aneurysm during exercise. Gated blood pool studies. Am J Med. 1986 Nov; 81(5):887-9. PMID: 3776992.
      Citations: 2     Fields:    Translation:Humans
    120. Thadani U, Hamilton SF, Olson E, Anderson J, Voyles W, Prasad R, Teague SM. Transdermal nitroglycerin patches in angina pectoris. Dose titration, duration of effect, and rapid tolerance. Ann Intern Med. 1986 Oct; 105(4):485-92. PMID: 3092711.
      Citations: 19     Fields:    Translation:HumansCTClinical Trials
    121. Teague SM, Heinsimer JA, Anderson JL, Sublett K, Olson EG, Voyles WF, Thadani U. Quantification of aortic regurgitation utilizing continuous wave Doppler ultrasound. J Am Coll Cardiol. 1986 Sep; 8(3):592-9. PMID: 3528265.
      Citations: 13     Fields:    Translation:Humans
    122. Thadani U. Improvement in angina pectoris with alpha adrenoceptor blockade. Br Heart J. 1986 Feb; 55(2):219-20. PMID: 3510644.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    123. Shapiro W, DiBianco R, Thadani U. Comparative efficacy of 200, 300 and 400 mg of bepridil for chronic stable angina pectoris. Am J Cardiol. 1985 Mar 15; 55(7):36C-42C. PMID: 3919556.
      Citations: 4     Fields:    Translation:HumansCTClinical Trials
    124. Thadani U. Anti-anginal and anti-ischemic efficacy of conventional and slow release formulations of isosorbide-5-mononitrate in angina pectoris. Z Kardiol. 1985; 74 Suppl 4:21-4. PMID: 4096067.
      Citations: 1     Fields:    Translation:Humans
    125. Thadani U. Assessment of "optimal" beta blockade in treating patients with angina pectoris. Acta Med Scand Suppl. 1985; 694:178-87. PMID: 2860773.
      Citations: 3     Fields:    Translation:Humans
    126. Thadani U. Nitrates for angina pectoris. A critical review of therapeutic efficacy and tolerance. Herz. 1984 Jun; 9(3):123-36. PMID: 6430766.
      Citations: 2     Fields:    Translation:Humans
    127. Thadani U. Beta blockers in hypertension. Am J Cardiol. 1983 Nov 10; 52(9):10D-15D. PMID: 6139008.
      Citations: 3     Fields:    Translation:Humans
    128. Thadani U, Kellerman D. Interaction of indomethacin and nitroglycerin on hemodynamics and exercise tolerance in patients with angina pectoris. Z Kardiol. 1983; 72 Suppl 3:35-9. PMID: 6421013.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    129. Burow RD, Wilson MF, Heath PW, Corn CR, Amil A, Thadani U. Influence of attenuation on radionuclide stroke volume determinations. J Nucl Med. 1982 Sep; 23(9):781-5. PMID: 7108624.
      Citations: 7     Fields:    Translation:HumansCells
    130. Thadani U. Beta adrenergic blocking agents for exertional angina pectoris. Herz. 1982 Jun; 7(3):179-87. PMID: 6124493.
      Citations:    Fields:    Translation:Humans
    131. Thadani U, Fung HL, Darke AC, Parker JO. Oral isosorbide dinitrate in angina pectoris: comparison of duration of action an dose-response relation during acute and sustained therapy. Am J Cardiol. 1982 Feb 01; 49(2):411-9. PMID: 7058754.
      Citations: 48     Fields:    Translation:HumansCTClinical Trials
    132. Fung HL, McNiff EF, Ruggirello D, Darke A, Thadani U, Parker JO. Kinetics of isosorbide dinitrate and relationships to pharmacological effects. Br J Clin Pharmacol. 1981 Jun; 11(6):579-89. PMID: 7272174.
      Citations: 14     Fields:    Translation:HumansCellsCTClinical Trials
    133. Olowoyeye JO, Thadani U, Parker JO. Slow release oxprenolol in angina pectoris: study comparing oxprenolol, once daily, with propranolol, four times daily. Am J Cardiol. 1981 May; 47(5):1123-7. PMID: 7223659.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    134. Thadani U, Manyari D, Gregor P, Olowoyeye J, Leach A, West RO, Parker JO. Hemodynamic effects of disopyramide at rest and during exercise in normal subjects. Cathet Cardiovasc Diagn. 1981; 7(1):27-34. PMID: 7214518.
      Citations: 2     Fields:    Translation:Humans
    135. Thadani U, Fung HL, Darke AC, Parker JO. Oral isosorbide dinitrate in the treatment of angina pectoris. Dose-response relationship and duration of action during acute therapy. Circulation. 1980 Sep; 62(3):491-502. PMID: 7398008.
      Citations: 18     Fields:    Translation:HumansCTClinical Trials
    136. Thadani U, Parker JO. Propranolol in angina pectoris: comparison of therapy given two and four times daily. Am J Cardiol. 1980 Jul; 46(1):117-23. PMID: 7386384.
      Citations: 3     Fields:    Translation:Humans
    137. Thadani U, Lewis JR, Manyari D, Boroomand K, Cohen J, West RO, Parker JO. Are the clinical and hemodynamic events during exercise stress testing in invasive studies in patients with angina pectoris reproducible? Circulation. 1980 Apr; 61(4):744-50. PMID: 7357716.
      Citations: 1     Fields:    Translation:Humans
    138. Thadani U, Manyari D, Parker JO, Fung HL. Tolerance to the circulatory effects of oral isosorbide dinitrate. Rate of development and cross-tolerance to glyceryl trinitrate. Circulation. 1980 Mar; 61(3):526-35. PMID: 6766360.
      Citations: 25     Fields:    Translation:HumansCTClinical Trials
    139. Thadani U, Davidson C, Singleton W, Taylor SH. Comparison of five beta-adrenoreceptor antagonists with different ancillary properties during sustained twice daily therapy in angina pectoris. Am J Med. 1980 Feb; 68(2):243-50. PMID: 6101934.
      Citations: 15     Fields:    Translation:HumansCTClinical Trials
    140. Thadani U, Chiong MA, Parker JO. Effects of low and high glucose in a glucose-insulin-potassium infusion on hemodynamics and exercise tolerance in patients with angina pectoris. Circulation. 1980 Feb; 61(2):266-76. PMID: 7351052.
      Citations: 2     Fields:    Translation:Humans
    141. Olowoyeye JO, Thadani U, Charrette EJ, Salerno TA, Parker JO. Subaortic annular left ventricular aneurysm: an unusual cause of aortic regurgitation. Cathet Cardiovasc Diagn. 1980; 6(3):285-91. PMID: 6449996.
      Citations:    Fields:    Translation:Humans
    142. Thadani U, Lewis JR, Mathew TM, West RO, Parker JO. Reproducibility of clinical and hemodynamic parameters during pacing stress testing in patients with angina pectoris. Circulation. 1979 Nov; 60(5):1036-44. PMID: 487537.
      Citations: 6     Fields:    Translation:Humans
    143. Parker JO, Thadani U. Cardiac performance at rest and during exercise in normal subjects. Bull Eur Physiopathol Respir. 1979 Sep-Oct; 15(5):935-49. PMID: 508986.
      Citations: 9     Fields:    Translation:Humans
    144. Thadani U, Lewis RJ, West RO, Chiong MA, Parker JO. Clinical, hemodynamic and metabolic responses during pacing in the supine and sitting postures in patients with angina pectoris. Am J Cardiol. 1979 Aug; 44(2):249-56. PMID: 463763.
      Citations:    Fields:    Translation:Humans
    145. Thadani U, Parker JO. Propranolol in angina pectoris: duration of improved exercise tolerance and circulatory effects after acute oral administration. Am J Cardiol. 1979 Jul; 44(1):118-25. PMID: 377932.
      Citations: 6     Fields:    Translation:HumansCTClinical Trials
    146. Thadani U, Davidson C, Singleton W, Taylor SH. Comparison of the immediate effects of five beta-adrenoreceptor-blocking drugs with different ancillary properties in angina pectoris. N Engl J Med. 1979 Apr 05; 300(14):750-5. PMID: 581782.
      Citations: 21     Fields:    Translation:HumansCTClinical Trials
    147. Thadani U, Parker JO. Propranolol in the treatment of angina pectoris. Comparison of duration of action in acute and sustained oral therapy. Circulation. 1979 Mar; 59(3):571-9. PMID: 761338.
      Citations: 7     Fields:    Translation:Humans
    148. Thadani U, Chiong MA, Parker JO. Effects of glucose-insulin-potassium infusion on the angina response during treadmill exercise. Cardiology. 1979; 64(6):333-49. PMID: 389419.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    149. Thadani U, Parker JO. Influence of glyceryl trinitrate during supine and upright exercise in patients with angina pectoris. Br Heart J. 1978 Nov; 40(11):1229-36. PMID: 102331.
      Citations: 4     Fields:    Translation:Humans
    150. Thadani U, Parker JO. Hemodynamics at rest and during supine and sitting bicycle exercise in normal subjects. Am J Cardiol. 1978 Jan; 41(1):52-9. PMID: 623005.
      Citations: 38     Fields:    Translation:Humans
    151. Thadani U, Lynn RB, Parker JO. Submitral annular left ventricular aneurysm--unusual echocardiographic and angiographic features. Cathet Cardiovasc Diagn. 1978; 4(2):163-74. PMID: 667919.
      Citations: 1     Fields:    Translation:Humans
    152. Goldstraw PW, Taylor SH, Thadani U, Watt SJ. Slow release oxprenolol in angina pectoris [proceedings]. Br J Clin Pharmacol. 1977 Jun; 4(3):387P. PMID: 332219.
      Citations: 3     Fields:    Translation:HumansCTClinical Trials
    153. Thadani U, West RO, Mathew TM, Parker JO. Hemodynamics at rest and during supine and sitting bicycle exercise in patients with coronary artery disease. Am J Cardiol. 1977 May 26; 39(6):776-83. PMID: 871106.
      Citations: 8     Fields:    Translation:Humans
    154. Taylor SH, Davidson C, Singleton W, Thadani U. Comparative anti-hypertensive effectiveness of beta-adrenoreceptor antagonists with different pharmacological properties: dose-response studies during acute and chronic administration. Clin Sci Mol Med Suppl. 1976 Dec; 3:541s-544s. PMID: 15760.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    155. Taylor SH, Thadani U. Oxprenolol in angina pectoris [proceedings]. Br J Pharmacol. 1976 Nov; 58(3):412P. PMID: 990603.
      Citations: 1     Fields:    Translation:Humans
    156. Davidson C, Thadani U, Singleton W, Taylor SH. Comparison of antihypertensive activity of beta-blocking drugs during chronic treatment. Br Med J. 1976 Jul 03; 2(6026):7-9. PMID: 7342.
      Citations: 27     Fields:    Translation:HumansCTClinical Trials
    157. Taylor SH, Davidson C, Singleton W, Thadani U. Proceedings: Comparison of antihypertensive effectiveness of beta-adrenoceptor antagonists with different pharmacological properties. Br Heart J. 1976 Mar; 38(3):313. PMID: 4081.
      Citations: 2     Fields:    Translation:Humans
    158. Iveson JM, Thadani U, Ionescu M, Wright V. Aortic valve incompetence and replacement in rheumatoid arthritis. Ann Rheum Dis. 1975 Aug; 34(4):312-20. PMID: 1190851.
      Citations: 15     Fields:    Translation:Humans
    159. Taylor SH, Thadani U, Davidson C, singleton W, Myint S. A comparative study of the activity of beta-adrenoceptor antagonists in man. Int J Clin Pharmacol Biopharm. 1975 Jul; 12(1-2):305-6. PMID: 240783.
      Citations: 3     Fields:    Translation:Humans
    160. Thadani U, Iveson JM, Wright V. Cardiac tamponade, constrictive pericarditis and pericardial resection in rheumatoid arthritis. Medicine (Baltimore). 1975 May; 54(3):261-70. PMID: 1143088.
      Citations: 20     Fields:    Translation:Humans
    161. Thadani U, Whitaker W, Watson DA. Congenital intrapericardial aneurysms of the left atrium. Thorax. 1975 Feb; 30(1):102-9. PMID: 1124523.
      Citations: 4     Fields:    Translation:Humans
    162. Thadani U, Burrow C, Whitaker W, Heath D. Pulmonary veno-occlusive disease. Q J Med. 1975 Jan; 44(173):133-59. PMID: 1153689.
      Citations: 9     Fields:    Translation:Humans
    163. Thadani U, Aber CP, Taylor JJ. Massive splenomegaly, pancytopenia and haemolytic anaemia in sarcoidosis. Acta Haematol. 1975; 53(4):230-40. PMID: 808933.
      Citations: 5     Fields:    Translation:Humans
    164. Sharma B, Raphael MJ, Thadani U, Taylor SH, Steiner RE, Goodwin JF. Proceedings: Left ventricular pressure-volume changes during exercise-induced pain in patients with angina pectoris. Br Heart J. 1974 Oct; 36(10):1038. PMID: 4433445.
      Citations: 1     Fields:    Translation:Humans
    165. Sharma B, Thadani U, Taylor SH. Cardiovascular effects of weight reduction in obese patients with angina pectoris. Br Heart J. 1974 Sep; 36(9):854-8. PMID: 4425600.
      Citations:    Fields:    Translation:Humans
    166. Thadani U. Rheumatoid lung disease with pulmonary fibrosis necrobiotic nodules and pleural effusion. Br J Dis Chest. 1973 Apr; 67(2):146-52. PMID: 4715613.
      Citations: 1     Fields:    Translation:Humans
    167. Thadani U, Sharma B, Meeran MK, Majid PA, Whitaker W, Taylor SH. Comparison of adrenergic beta-receptor antagonists in angina pectoris. Br Med J. 1973 Jan 20; 1(5846):138-42. PMID: 4145234.
      Citations: 24     Fields:    Translation:HumansCTClinical Trials
    168. Chopra MP, Thadani U, Aber CP, Portal RW, Parkes J. Plasma cortisol, urinary 17-hydroxycorticoids, and urinary vanilyl mandelic acid after acute myocardial infarction. Br Heart J. 1972 Oct; 34(10):992-7. PMID: 5086981.
      Citations: 3     Fields:    Translation:Humans
    169. Chopra MP, Thadani U, Portal RW, Aber CP. Lignocaine therapy for ventricular ectopic activity after acute myocardial infarction: a double-blind trial. Br Med J. 1971 Sep 18; 3(5776):668-70. PMID: 4936439.
      Citations: 14     Fields:    Translation:HumansCTClinical Trials
    170. Thadani U, Pratt AE. Profunda femoral arteriovenous fistula after percutaneous arterial and venous catheterization. Br Heart J. 1971 Sep; 33(5):803-5. PMID: 5115025.
      Citations:    Fields:    Translation:Humans
    171. Thadani U, Chopra MP, Aber CP, Portal RW. Pericarditis after acute myocardial infarction. Br Med J. 1971 Apr 17; 2(5754):135-7. PMID: 5581490.
      Citations: 9     Fields:    Translation:Humans
    Thadani's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (454)
    Explore
    _
    Co-Authors (9)
    Explore
    _
    Similar People (57)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _